Alessandra Boccaccino

Ravenna, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 61 publications

Baseline neutrophil-to-eosinophil ratio and neutrophil-to-lymphocyte ratio as prognostic markers in patients with unresectable biliary tract cancer treated with gemcitabine-cisplatin-durvalumab: an international, multicentre, retrospective cohort study.

Baseline neutrophil-to-eosinophil ratio and neutrophil-to-lymphocyte ratio as prognostic markers in patients with unresectable biliary tract cancer treated with gemcitabine-cisplatin-durvalumab: an international, multicentre, retrospective cohort study.

Journal: ESMO gastrointestinal oncology

Published: May 22, 2026

Predictive Immunohistochemistry in Cholangiocarcinoma: Current Clinical Utility, Practical Limitations, and Emerging Directions.

Predictive Immunohistochemistry in Cholangiocarcinoma: Current Clinical Utility, Practical Limitations, and Emerging Directions.

Journal: APMIS : acta pathologica, microbiologica, et immunologica Scandinavica

Published: March 06, 2026

Clinicopathological features of mismatch repair-deficient colorectal cancer: an observational experience from Romagna, Italy.

Clinicopathological features of mismatch repair-deficient colorectal cancer: an observational experience from Romagna, Italy.

Journal: Minerva gastroenterology

Published: January 30, 2026

Management of Elderly Colorectal Cancer Patients: A Comprehensive Review Encompassing Geriatric Assessment.

Management of Elderly Colorectal Cancer Patients: A Comprehensive Review Encompassing Geriatric Assessment.

Journal: Cancers

Published: September 04, 2025

Genomic pathway alterations and their prognostic impact in biliary tract cancer: Insights from a multinational cohort treated with cisplatin, gemcitabine, and durvalumab.

Genomic pathway alterations and their prognostic impact in biliary tract cancer: Insights from a multinational cohort treated with cisplatin, gemcitabine, and durvalumab.

Journal: European journal of cancer (Oxford, England : 1990)

Published: August 01, 2025

Prognostic impact and clinical management of pT4N0 colon cancer: data from a large, multicenter, international, real-world dataset.

Prognostic impact and clinical management of pT4N0 colon cancer: data from a large, multicenter, international, real-world dataset.

Journal: ESMO open

Published: April 11, 2025

A Prognostic Index for Advanced Biliary Tract Cancer Treated With Cisplatin, Gemcitabine and Durvalumab: The MAGIC-D Index.

A Prognostic Index for Advanced Biliary Tract Cancer Treated With Cisplatin, Gemcitabine and Durvalumab: The MAGIC-D Index.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: March 31, 2025

The impact of molecular alterations in patients with advanced biliary tract cancer receiving cisplatin, gemcitabine, and durvalumab: a large, real-life, worldwide population.

The impact of molecular alterations in patients with advanced biliary tract cancer receiving cisplatin, gemcitabine, and durvalumab: a large, real-life, worldwide population.

Journal: Journal of the National Cancer Institute

Published: March 11, 2025

Negative impact of corticosteroid use on outcome in patients with advanced BTCs treated with cisplatin, gemcitabine, and durvalumab: A large real-life worldwide population.

Negative impact of corticosteroid use on outcome in patients with advanced BTCs treated with cisplatin, gemcitabine, and durvalumab: A large real-life worldwide population.

Journal: International journal of cancer

Published: January 29, 2025

Factors associated with reaching maintenance therapy in patients with advanced biliary tract cancer treated with durvalumab: Real-world results from a multicenter and multinational study.

Factors associated with reaching maintenance therapy in patients with advanced biliary tract cancer treated with durvalumab: Real-world results from a multicenter and multinational study.

Journal: International journal of cancer

Published: October 19, 2024

Efficacy of cisplatin-gemcitabine-durvalumab in patients with advanced biliary tract cancer experiencing early vs late disease relapse after surgery: a large real-life worldwide population.

Efficacy of cisplatin-gemcitabine-durvalumab in patients with advanced biliary tract cancer experiencing early vs late disease relapse after surgery: a large real-life worldwide population.

Journal: The oncologist

Published: August 16, 2024

Corrigendum to "Plasmatic BRAF-V600E allele fraction as a prognostic factor in metastatic colorectal cancer treated with BRAF combinatorial treatments": [Annals of Oncology 34 (2023) 543-552].

Corrigendum to "Plasmatic BRAF-V600E allele fraction as a prognostic factor in metastatic colorectal cancer treated with BRAF combinatorial treatments": [Annals of Oncology 34 (2023) 543-552].

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: August 13, 2024

Showing 1-12 of 61

Last Updated: 09/26/2026